DK3391875T3 - Fremgangsmåde til fremstilling af polymer micelle, der indeholder et anionisk lægemiddel - Google Patents
Fremgangsmåde til fremstilling af polymer micelle, der indeholder et anionisk lægemiddel Download PDFInfo
- Publication number
- DK3391875T3 DK3391875T3 DK16876080.9T DK16876080T DK3391875T3 DK 3391875 T3 DK3391875 T3 DK 3391875T3 DK 16876080 T DK16876080 T DK 16876080T DK 3391875 T3 DK3391875 T3 DK 3391875T3
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- preparation
- medicinal product
- polymer micelle
- micelle containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20150182265 | 2015-12-18 | ||
PCT/KR2016/014821 WO2017105138A1 (ko) | 2015-12-18 | 2016-12-16 | 음이온성 약물을 함유하는 고분자 미셀의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3391875T3 true DK3391875T3 (da) | 2022-01-24 |
Family
ID=59056947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16876080.9T DK3391875T3 (da) | 2015-12-18 | 2016-12-16 | Fremgangsmåde til fremstilling af polymer micelle, der indeholder et anionisk lægemiddel |
Country Status (12)
Country | Link |
---|---|
US (1) | US20180344638A1 (da) |
EP (1) | EP3391875B1 (da) |
JP (1) | JP6599560B2 (da) |
KR (1) | KR101870316B1 (da) |
CN (1) | CN108366964B (da) |
AU (1) | AU2016372321B2 (da) |
CA (1) | CA3008788C (da) |
DK (1) | DK3391875T3 (da) |
ES (1) | ES2901102T3 (da) |
NZ (1) | NZ743320A (da) |
PT (1) | PT3391875T (da) |
WO (1) | WO2017105138A1 (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102175069B1 (ko) * | 2017-11-10 | 2020-11-05 | 주식회사 삼양바이오팜 | 음이온성 약물 전달용 지질 나노입자의 동결건조 조성물 및 방법 |
KR102259513B1 (ko) * | 2017-11-16 | 2021-06-02 | 주식회사 삼양홀딩스 | 음이온성 약물 함유 약제학적 조성물의 동결건조 조성물 및 방법 |
CN110179749B (zh) * | 2018-04-27 | 2020-09-01 | 中山大学 | 可用于治疗类风湿性关节炎的聚合物纳米颗粒 |
WO2020032581A1 (ko) * | 2018-08-07 | 2020-02-13 | 주식회사 삼양바이오팜 | 바이러스 전달용 고분자 나노입자 조성물 및 그의 제조방법 |
BR112021006539A2 (pt) | 2018-10-09 | 2021-07-06 | Univ British Columbia | composições e sistemas competentes de vesículas competentes para transfecção isentas de solventes e detergentes orgânicos e métodos relacionados às mesmas |
CA3157437A1 (en) * | 2019-11-07 | 2021-05-14 | So Jin Lee | Polymer nanoparticle composition for inducing immunity and preparation method therefor |
WO2021101265A1 (ko) * | 2019-11-22 | 2021-05-27 | 주식회사 삼양바이오팜 | 약물전달용 나노입자 조성물 제조용 키트 |
KR20220082975A (ko) * | 2020-12-10 | 2022-06-20 | 주식회사 삼양홀딩스 | 재건 시간을 단축할 수 있는 고분자 미셀 나노입자의 제조 방법 |
CN114569577B (zh) * | 2022-03-07 | 2023-04-11 | 晟迪生物医药(苏州)有限公司 | 一种聚合物包衣纳米粒及其制备方法 |
KR20240035317A (ko) * | 2022-09-08 | 2024-03-15 | 주식회사 삼양홀딩스 | 약물 함유 나노입자 제조용 키트 및 약물전달용 나노입자 조성물 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1037611B1 (en) * | 1997-12-12 | 2008-10-29 | Samyang Corporation | Biodegradable mixed polymeric micelles for gene delivery |
WO2001075164A2 (en) | 2000-03-30 | 2001-10-11 | Whitehead Institute For Biomedical Research | Rna sequence-specific mediators of rna interference |
KR100373844B1 (ko) * | 2000-09-21 | 2003-02-26 | 굿젠 주식회사 | 유전자 및 생물학적 활성 약물 전달용 양이온성 지질과이의 제조방법 |
TR200401292T3 (tr) | 2000-12-01 | 2004-07-21 | Max@Planck@Gesellschaft�Zur�F�Rderung�Der�Wissenschaften | RNAÁgirişimineÁyolÁaçanÁküçükÁRNAÁmolekülleri |
CA2564719C (en) * | 2004-05-06 | 2011-11-01 | Samyang Corporation | Delivery system for bioactive agents on the basis of a polymeric drug carrier comprising an amphiphilic block polymer and a polylactic acid derivative |
KR100949791B1 (ko) | 2007-12-18 | 2010-03-30 | 이동기 | 오프-타겟 효과를 최소화하고 RNAi 기구를 포화시키지않는 신규한 siRNA 구조 및 그 용도 |
EP2296630A2 (en) * | 2008-05-07 | 2011-03-23 | SurModics, Inc. | Delivery of nucleic acid complexes from particles |
US20110142951A1 (en) * | 2008-05-13 | 2011-06-16 | University Of Washington | Micelles for intracellular delivery of therapeutic agents |
AU2009330859B2 (en) * | 2008-12-26 | 2013-06-20 | Samyang Holdings Corporation | Pharmaceutical composition containing an anionic drug, and a production method therefor |
KR101296326B1 (ko) * | 2009-12-30 | 2013-08-14 | 주식회사 삼양바이오팜 | 폴리락트산을 포함하는 음이온성 약물 전달용 조성물 및 그 제조 방법 |
US20120078661A1 (en) * | 2010-09-28 | 2012-03-29 | Scan Am Company | Health Care Facility Management and Information System |
EP2658577A4 (en) * | 2010-12-30 | 2016-08-24 | Samyang Biopharmaceuticals | CARRIER FOR NEGATIVELY LOADED MEDICAMENTS WITH A CATIONIC LIPID AND METHOD FOR THE PRODUCTION THEREOF |
KR101508275B1 (ko) * | 2011-12-16 | 2015-04-08 | 주식회사 삼양바이오팜 | 고분자 나노입자 수용액 조성물 및 그 제조방법 |
EP2833869B1 (en) * | 2012-04-04 | 2020-10-28 | Samyang Biopharmaceuticals Corporation | Method of preparing composition for delivering an anionic drug |
WO2017048018A1 (ko) * | 2015-09-15 | 2017-03-23 | 주식회사 삼양바이오팜 | 음이온성 약물 함유 약제학적 조성물 및 그 제조방법 |
AU2016324450B2 (en) * | 2015-09-15 | 2019-04-18 | Samyang Holdings Corporation | Pharmaceutical composition containing anionic drug, and preparation method therefor |
-
2016
- 2016-12-16 NZ NZ743320A patent/NZ743320A/en unknown
- 2016-12-16 DK DK16876080.9T patent/DK3391875T3/da active
- 2016-12-16 KR KR1020160172716A patent/KR101870316B1/ko active IP Right Grant
- 2016-12-16 WO PCT/KR2016/014821 patent/WO2017105138A1/ko active Application Filing
- 2016-12-16 US US15/781,182 patent/US20180344638A1/en not_active Abandoned
- 2016-12-16 PT PT168760809T patent/PT3391875T/pt unknown
- 2016-12-16 CN CN201680074444.7A patent/CN108366964B/zh active Active
- 2016-12-16 EP EP16876080.9A patent/EP3391875B1/en active Active
- 2016-12-16 CA CA3008788A patent/CA3008788C/en active Active
- 2016-12-16 ES ES16876080T patent/ES2901102T3/es active Active
- 2016-12-16 AU AU2016372321A patent/AU2016372321B2/en active Active
- 2016-12-16 JP JP2018530060A patent/JP6599560B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
EP3391875A4 (en) | 2019-08-14 |
PT3391875T (pt) | 2021-12-20 |
EP3391875A1 (en) | 2018-10-24 |
JP6599560B2 (ja) | 2019-10-30 |
AU2016372321B2 (en) | 2019-01-24 |
AU2016372321A1 (en) | 2018-06-28 |
US20180344638A1 (en) | 2018-12-06 |
NZ743320A (en) | 2019-03-29 |
KR101870316B1 (ko) | 2018-06-22 |
WO2017105138A1 (ko) | 2017-06-22 |
CA3008788C (en) | 2021-05-25 |
EP3391875B1 (en) | 2021-11-03 |
KR20170073528A (ko) | 2017-06-28 |
ES2901102T3 (es) | 2022-03-21 |
CN108366964B (zh) | 2022-04-08 |
JP2019501900A (ja) | 2019-01-24 |
CN108366964A (zh) | 2018-08-03 |
CA3008788A1 (en) | 2017-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3391875T3 (da) | Fremgangsmåde til fremstilling af polymer micelle, der indeholder et anionisk lægemiddel | |
DK3463248T3 (da) | Anordnnger til anvendelse af lægemiddelanordninger | |
MA41265A (fr) | Compositions pour administration de médicaments iléo-jéjunal. | |
DK3096741T3 (da) | Fremgangsmåde til fremstillingen af hybridosomer | |
DK3191502T3 (da) | Målrettet indgivelse af tertiært aminholdige lægemiddelstoffer | |
DK3192902T3 (da) | Fremgangsmåde til fremstilling af graphenholdige viscosefibre | |
CL2016002569A1 (es) | Anticuerpos, composiciones farmacéuticas y usos de los mismos | |
DK3722274T3 (da) | 2-perfluorbutylpentan til oftalmisk indgivelse | |
DK3174858T3 (da) | Fremgangsmåde til fremstilling af pyrazoler | |
DK3481838T3 (da) | Nye fremgangsmåder til fremstillingen af oligonukleotider | |
DK3357491T3 (da) | Farmaceutisk sammensætning til afgivelse af et anionisk medikament | |
DK3325443T3 (da) | Fremgangsmåde til fremstilling af pridopidin | |
MA52906A (fr) | Procédé de préparation d'amg 416 | |
DK3204398T3 (da) | Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer | |
DK3237045T3 (da) | Indretning til indgivelse af lægemidler | |
DK3383436T3 (da) | Forbedret fremgangsmåde til fremstilling af indocyaningrønt | |
DK3359522T3 (da) | Proces til fremstilling af N-Boc-bifenylalaninol | |
DK3233813T3 (da) | Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser | |
DK3236783T3 (da) | Fremgangsmåde til forøgelse af stabiliteten af en sammensætning, der omfatter flerumættede omega-6-fedtsyrer | |
DK3280408T3 (da) | Fremgangsmåde til fremstilling af dicycloplatin | |
DK3325483T3 (da) | Fremgangsmåder til fremstilling af cytotoksiske benzodiazepinderivater | |
DK3166611T3 (da) | Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxypicolinsyrer | |
DK3331495T3 (da) | Flydende polymerleveringssystem til forlænget indgivelse af lægemidler | |
DK3537881T3 (da) | Fremgangsmåder til fremstilling af bageriprodukter ud af partikelblandinger | |
MA42964A (fr) | Préparation pharmaceutique anti-vieillissement |